Rentschler Biopharma

Rentschler Biopharma, founded in 1927, is a family-owned and independent company that specializes in contract development and manufacturing organization (CDMO) services for the biopharmaceutical industry. The company offers comprehensive solutions that encompass bioprocess development, cGMP manufacturing, and aseptic filling of biopharmaceuticals, alongside consulting services for regulatory approvals and project management. Rentschler Biopharma has built a strong reputation in the field, particularly in the early biotechnology sector with its development of Interferon products. The company focuses on various therapeutic molecules, including antibodies, fusion proteins, and enzymes. Rentschler Biopharma prides itself on its efficient decision-making processes and operational excellence, ensuring that project timelines are met while maintaining high standards of product quality and productivity through innovative technologies.